|
⚲
|
| Keyboard |
| Consonance Capital Management LP
✚
|
|
|---|---|
| CRD # | 162717 |
| SEC # | 801-75000 |
| CIK # | 0001544773 |
| AUM | |
| Employees | 4 (75% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-660-8060 |
| Address | 1370 Avenue of The Americas New York, NY 10019 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Consonance-HFW Acquisition Corp | 7.1 | ||
| Consonance-HFW Acquisition Corp | 0.2 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Consonance Capital Opportunity Master Fund LP | [2020-02-27] | 82.5 M | 16.9 M |
| Filed 2021-01-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Consonance Capital Co-Invest LLC Series A | [2019-03-01] | 1.5 M | |
| Filed 2019-01-28 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Consonance Capital Master Account LP | [2012-03-27] | 708.7 M | 27.5 M |
| Filed 2021-02-25 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Finder's Fee $2,904,291 · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 0.0 |
| By Discretionary | ||
| Discretionary | 6 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 6 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Mitchell Blutt | Executive Officer | 8 | 3 | |
| Mitchell Blutt MD | Executive Officer | 7 | 3 | |
| Benny Soffer | Executive Officer | 4 | 2 | |
| Douglas Lewis | Executive Officer | 3 | 2 | |
| Kevin Livingston | Executive Officer | 3 | 1 | |
| Reza Keshavarz | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001544773] | |
| 3 | [0001544773] | |
| 4 | [0001544773] | |
| SC 13D | [0001544773] | |
| SC 13G | [0001544773] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.5B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300UFH280DE39TF17 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2022-12-14 | Sell | 150,275 | ||
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2022-12-14 | Sell | 144,666 | ||
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2022-12-14 | Sell | 582,916 | ||
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2022-12-14 | Sell | 432,639 | ||
|
Surrozen Inc/DE SRZN
Common Stock
|
2022-12-14 | Sell | 1,748,750 | ||
|
Surrozen Inc/DE SRZN
Common Stock
|
2022-12-14 | Sell | 1,885,000 | ||
|
Surrozen Inc/DE SRZN
Common Stock
|
2022-12-14 | Sell | 450,827 | ||
|
Surrozen Inc/DE SRZN
Common Stock
|
2022-12-14 | Sell | 1,297,922 | ||
|
Surrozen Inc/DE SRZN
Common Stock
|
2021-08-11 | Grant | 500,000 | ||
|
Surrozen Inc/DE SRZN
Class A Ordinary Shares
|
2021-08-11 | Disposed to issuer | 500,000 | ||
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2021-08-11 | Grant | 416,250 | ||
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2021-08-11 | Grant | 308,940 | ||
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2021-08-11 | Buy | 166,667 | ||
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2021-08-11 | Buy | 123,700 | ||
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2021-08-11 | Buy | 42,966 | ||
|
Surrozen Inc/DE SRZN
Warrants (right to buy) · derivative
|
2021-08-11 | Grant | 107,309 | ||
|
Surrozen Inc/DE SRZN
Common Stock
|
2021-08-11 | Grant | 371,100 | ||
|
Surrozen Inc/DE SRZN
Common Stock
|
2021-08-11 | Grant | 321,928 | ||
|
Surrozen Inc/DE SRZN
Common Stock
|
2021-08-11 | Grant | 926,822 | ||
|
Surrozen Inc/DE SRZN
Common Stock
|
2021-08-11 | Grant | 1,248,750 | ||
| showing 20 of 27 most recent transactions | |||||
| Related Firms | State | AUM |
|---|---|---|
|
Consonance Capital Partners LP
✚
|
NY | 2,761.9 M |
|
Consonance Capital Management LP
✚
|
NY |